BRVE Earnings
Braveheart Bio, Inc.
1W: +13.8%
1M: +6.1%
YTD: +21.5%
$21.82
-0.05 (-0.23%)
Weekly Expected Move ±10.2%
$17
$19
$21
$24
$26
Credit Risk of going bust: not rated Bonds: none of note held by US funds details ▾
Not rated: no recent balance sheet.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-09-08
EPS
$-2.51
▼ Miss -193.3%
Revenue
—
Next Earnings
2026-12-08
EPS Estimate
$-0.91
Estimate vs Actual
Earnings Surprise History
0/1
EPS Beats
0/1
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Earnings Call Transcripts
No transcripts available.